Entera Bio Ltd. Warrant
ENTXW
ENTXW was delisted on the 27th of June, 2023.
2 hedge funds and large institutions have $1K invested in Entera Bio Ltd. Warrant in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
75% less capital invested
Capital invested by funds: $4K → $1K (-$3K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$221 |
ENTXW Hedge Fund Activity: Q2 2022 in Review
2 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q2 2022, worth a combined $1K — down 75% from $4K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ENTXW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Virtu Financial, cutting an estimated $221.
- 2 institutional investors held Entera Bio Ltd. Warrant (ENTXW) as of Q2 2022, down from 3 in Q1 2022.
- Funds reported $1K of Entera Bio Ltd. Warrant stock for Q2 2022, down 75% quarter-over-quarter.
- 0 funds opened new Entera Bio Ltd. Warrant positions in Q2 2022 and 1 closed out, a net change of -1 holder.
- The largest Entera Bio Ltd. Warrant seller in Q2 2022 was Virtu Financial, an estimated $221 sold.
Based on aggregated 13F filings for Q2 2022.